Biotarget is a company established in 2016 as a combination of scientific competences in the field of molecular biology, immunochemistry, but also business and commercialization competences.

Biotarget conducts R&D in the areas of immunomodulation, immunostimulation, medicinal products in the form of FSMPs, putting particular emphasis on cancer and infectious diseases.

Literature

  1. Skotnicki AB. Mielo- i immunotropowe właściwości hormonów grasiczych – zastosowanie kliniczne w hematologii i onkologii. Onkologia i Radioterapia.1(11); 2010.
  2. Yan F. Thymic function in the regulation of T cells, and molecular mechanisms underlying the modulation of cytokines and stress signaling (Review). Molecular Medicine Reports 16: 7175-7184, 2017.
  3. Thapa P. The role of the thymus in the role of immune response. Thorac Surg Clin. 2019 May; 29(2): 123–131.

Scroll to top